ARALEZ PHARMACEUTICALS INC - COM (ARLZ)

CUSIP: 03852X100

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / COM
Total 13F shares
5,000,239
Share change
-5,593,327
Total reported value
$1,750,796
Put/Call ratio
122%
Price per share
$0.35
Number of holders
31
Value change
-$4,042,773
Number of buys
14
Number of sells
23

Quarterly Holders Quick Answers

What is CUSIP 03852X100?
CUSIP 03852X100 identifies ARLZ - ARALEZ PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ARALEZ PHARMACEUTICALS INC - COM (ARLZ) as of Q2 2018

As of 30 Jun 2018, ARALEZ PHARMACEUTICALS INC - COM (ARLZ) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,000,239 shares. The largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), WELLS FARGO & COMPANY/MN, SALZHAUER MICHAEL, PAR CAPITAL MANAGEMENT INC, RENAISSANCE TECHNOLOGIES LLC, DEUTSCHE BANK AG\, Silverleafe Capital Partners, LLC, FRANKLIN STREET ADVISORS INC /NC, MACQUARIE GROUP LTD, and GOLDMAN SACHS GROUP INC. This page lists 31 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.